VIValentina V. Ignatova

Valentina V. Ignatova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Valentina V. Ignatova has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Adrián Sanz-Moreno

    Institute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany

    1 shared publication
  • Andrea Pavesi

    Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore

    1 shared publication
  • Birgit Rathkolb

    German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany

    1 shared publication
  • Chee Leng Lee

    Monash Institute of Pharmaceutical Sciences, Monash University, 399 Royal Parade, Parkville VIC 3052, Australia

    1 shared publication
  • Emil Ibragimov

    Institute of Functional Epigenetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany

    1 shared publication
  • Ernesto Guccione

    Center of OncoGenomics and Innovative Therapeutics (COGIT), Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

    1 shared publication

Latest Publications

  • Open Access

    METTL6 is a tRNA m 3 C methyltransferase that regulates pluripotency and tumor cell growth

    by Valentina V. Ignatova, Steffen Kaiser, Jessica Sook Yuin Ho, Xinyang Bing, Paul Stolz, Ying Xim Tan, Chee Leng Lee, Florence Pik Hoon Gay, Palma Rico Lastres, Raffaele Gerlini, et al.

    Recently, covalent modifications of RNA, such as methylation, have emerged as key regulators of all aspects of RNA biology and have been implicated in numerous diseases, for instance, cancer. Here, we undertook a combination of in vitro and in vivo screens to test 78 potential methyltransferases for their roles in hepatocellular carcinoma (HCC) cell proliferation. We identified methyltransferase-like protein 6 (METTL6) as a crucial regulator of tumor cell growth. We show that METTL6 is a bona fide transfer RNA (tRNA) methyltransferase, catalyzing the formation of 3-methylcytidine at C32 of specific serine tRNA isoacceptors. Deletion of Mettl6 in mouse stem cells results in changes in ribosome occupancy and RNA levels, as well as impaired pluripotency. In mice, Mettl6 knockout results in reduced energy expenditure. We reveal a previously unknown pathway in the maintenance of translation efficiency with a role in maintaining stem cell self-renewal, as well as impacting tumor cell growth profoundly.